Retatrutide
$550.00
Retatrutide
The Next Generation of Metabolic Research
Retatrutide is an investigational medication currently being studied for its potential role in weight management and metabolic health. Unlike existing GLP-1 medications, retatrutide is being researched as a triple hormone receptor agonist, targeting GLP-1, GIP, and glucagon receptors.
Clinical research is evaluating how this unique approach may influence appetite, energy balance, body weight, and metabolic function.
At BE TRT & Weight Loss Clinic, we believe in helping patients understand both today's treatment options and the therapies that may shape the future of medical weight management.
Potential areas currently being studied include:
Appetite and hunger regulation
Weight management
Metabolic health
Body composition
Energy expenditure
Important Notice
Retatrutide is an investigational medication and is not currently FDA-approved for weight loss or commercial use. BE TRT & Weight Loss Clinic does not represent retatrutide as an FDA-approved treatment. Information provided on this page is for educational purposes regarding ongoing clinical research.
Price Options
Reta Monthly
$550.00
every month for 3 months







